European Journal of Cancer and Clinical Oncology
Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer
References (25)
- et al.
Oestrogen receptors, sites of metastatic disease, and survival in recurrent breast cancer
Eur J Cancer
(1981) - et al.
Prognostic significance of ER status in breast cancer in relation to the tumour stage, axillary nodes, metatases and histopathologic grading
Cancer
(1984) - et al.
Oestrogen receptors and breast cancer: current status
Br J Surg
(1980) - et al.
The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer
Cancer
(1980) - et al.
The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast
Br J Cancer
(1985) - et al.
Soluble and nuclcear oestrogen receptor status in human breast cancer in relation to prognosis
Br J Cancer
(1981) - et al.
Progesterone receptor as a prognostic factor in Stage III breast cancer
New Eng J Med
(1983) - et al.
Steroid-hormone receptors and survival after first relapse in breast cancer
Lancet
(1984) - et al.
Oestrogen receptor status and sites of metastasis in breast cancer
Br J Cancer
(1981) - et al.
Oestrogen receptor concentration in primary breast cancer and axillary nodes metastases
Breast Cancer Res Treat
(1981)
Distribution of oestrogen and progesterone receptors in primary tumour and lymph nodes in individual patients with breast cancer
Tumori
Intratumoural variation of oestrogen receptor status in endometrial cancer
Br J Cancer
Cited by (38)
Receptor Imaging in Patients with Breast Cancer
2009, PET ClinicsCitation Excerpt :Thus, additional biopsies are needed to know the actual receptor status at the time of relapse to achieve second- or third-line treatment. In patients with acquired resistance to endocrine treatment, determining the actual ER status by biopsies is often difficult to perform, because systemic metastases can be difficult to access due to their location and receptor status can be discordant in 20% to 30% of simultaneous biopsies from a single patient.17,18 Conversion rates from ER-positive to ER-negative status of 29% to 31% have been reported, while conversion rates from ER-negative to ER-positive status have also been reported in a significant proportion (12%–33%) of cases between the assessment of ER expression in the primary tumor and relapse.18,19
Steroid Receptor Imaging in Breast Cancer
2006, PET ClinicsEvidence for soluble and nuclear site I binding of estrogens in human aorta
1993, Atherosclerosis